Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function

Hypertensive disorders affect about one third of all people aged 20 and above, and are treated with anti-hypertensive drugs. Preeclampsia (PE) is one form of such disorders that only develops during pregnancy. It affects ten million pregnant women globally and additionally causes fetal loss and majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Meiri, Hamutal, Osol, George, Cetin, Irene, Gizurarson, Sveinbjörn, Huppertz, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633742/
https://www.ncbi.nlm.nih.gov/pubmed/29034064
http://dx.doi.org/10.1016/j.csbj.2017.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633742/
https://www.ncbi.nlm.nih.gov/pubmed/29034064
http://dx.doi.org/10.1016/j.csbj.2017.09.002

Ejemplares similares